Published in Int J Lepr Other Mycobact Dis on May 25, 1977
Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem (2010) 1.80
Systematic review of clofazimine for the treatment of drug-resistant tuberculosis. Int J Tuberc Lung Dis (2013) 1.17
Molecular imaging of intracellular drug-membrane aggregate formation. Mol Pharm (2011) 0.96
Effects of antituberculosis and antileprosy drugs on mycobacteriophage D29 growth. Antimicrob Agents Chemother (1980) 0.83
Production of Superoxide in Bacteria Is Stress- and Cell State-Dependent: A Gating-Optimized Flow Cytometry Method that Minimizes ROS Measurement Artifacts with Fluorescent Dyes. Front Microbiol (2017) 0.75
Immune response to persistent mycobacterial infection in mice. Infect Immun (1978) 1.96
Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice. Infect Immun (1975) 1.53
Growth of mycobacterium bovis (BCG) in T lymphocyte-depleted mice. Infect Immun (1975) 1.32
Delayed hypersensitivity responses in mice and guinea pigs to Mycobacterium leprae, Mycobacterium vaccae, and Mycobacterium nonchromogenicum cytoplasmic proteins. Infect Immun (1979) 1.17
Effect of iron nutrition on the bound hydroxylamine content of Mycobacterium phlei. J Bacteriol (1968) 1.10
Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology (1999) 1.04
Immunogenicity of an aerogenic BCG vaccine in T-cell-depleted and normal mice. Infect Immun (1975) 1.02
Onchocerciasis. Onchocercal dermatitis, lymphadenitis, and elephantiasis in the Ubangi territory. Hum Pathol (1970) 0.99
Clofazimine analogues active against a clofazimine-resistant organism. J Med Chem (1988) 0.98
Peptide phage display: opportunities for development of personalized anti-cancer strategies. Anticancer Agents Med Chem (2006) 0.95
Restoration of delayed hypersensitivity to sheep erythrocytes by thymosin treatment of T-cell-depleted mice. Infect Immun (1976) 0.92
Microscopic counts carried out on Mycobacterium leprae and M. tuberculosis suspensions. A comparison of three staining procedures. Int J Lepr Other Mycobact Dis (1980) 0.92
Growth of Mycobacterium marinum in the footpads of T-cell-depleted mice. Infect Immun (1975) 0.91
Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. J Cell Biochem Suppl (1994) 0.91
Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones. J Gen Microbiol (1982) 0.89
Body composition of growing and adult cats as measured by use of dual energy X-ray absorptiometry. Comp Med (2000) 0.88
The mode of action of clofazimine DNA binding studies. Int J Lepr Other Mycobact Dis (1976) 0.87
Purification and properties of HindII and HindIII endonucleases from Haemophilus influenzae Rd. Methods Enzymol (1980) 0.85
Long-term primary culture of epithelial cells from rainbow trout Oncorhynchus mykiss) liver. In Vitro Cell Dev Biol Anim (1995) 0.83
Restoration of T-cell responsiveness by thymosin: development of antituberculous resistance in BCG-infected animals. Infect Immun (1976) 0.83
Mycobacterium leprae iron nutrition: bacterioferritin, mycobactin, exochelin and intracellular growth. Int J Lepr Other Mycobact Dis (1995) 0.83
Growth factor activity of mycobactin for Arthrobacter species. J Bacteriol (1966) 0.82
Molecular markers of glial tumors: current targeting strategies. Curr Med Chem (2003) 0.81
Alterations in the growth hormone/insulin-like growth factor I pathways in feline GM1 gangliosidosis. Endocrinology (1999) 0.81
Thymic alterations in feline GM1 gangliosidosis. Vet Immunol Immunopathol (1998) 0.80
Measurement of urinary N-acetyl-beta-D-glucosaminidase to assess renal ischemia during laparoscopic operations. Surg Endosc (1999) 0.80
Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones. J Med Chem (1974) 0.79
Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity. Int J Lepr Other Mycobact Dis (1981) 0.79
Development of secondary structure, growth characteristics and cytogenetic analysis of human transitional cell carcinoma xenografts in scid/scid mice. J Urol (1996) 0.78
2-Acetylpyridine thiosemicarbazones and Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1984) 0.78
Evaluation of GM1 ganglioside-mediated apoptosis in feline thymocytes. Vet Immunol Immunopathol (1998) 0.78
Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigens. Int J Lepr Other Mycobact Dis (1983) 0.77
Effect of locally injected medications on healing of pad wounds in dogs. Am J Vet Res (1996) 0.77
Restoration of T-cell responsiveness by thymosin: expression of anti-tuberculous immunity in mouse lungs. Infect Immun (1979) 0.75
The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat. Calcif Tissue Int (1989) 0.75
Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductase. J Med Chem (1974) 0.75
Comparative DNA binding studies with clofazimine and B1912. Int J Lepr Other Mycobact Dis (1977) 0.75
Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha*. Endocrinology (1990) 0.75
Sequential blockade of the mycobacterial de novo folate pathway. A review. Int J Lepr Other Mycobact Dis (1972) 0.75
Activity of 2-acetylpyridine and 2-acetylquinoline thiosemicarbazones tested in vitro in combination with other antituberculous drugs. Am Rev Respir Dis (1982) 0.75
Effect of immunosuppression on the multiplication of Mycobacrterium ulcerans in the mouse foot pad. Int J Lepr Other Mycobact Dis (1967) 0.75
Differences in binding affinities of human PTH(1-84) do not alter biological potency: a comparison between chemically synthesized hormone, natural and mutant forms. Peptides (1994) 0.75
Abortifacient activity of B1912. Int J Lepr Other Mycobact Dis (1979) 0.75